<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">19319041</PMID>
      <DateCompleted>
        <Year>2009</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1529-4242</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>123</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2009</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Plastic and reconstructive surgery</Title>
          <ISOAbbreviation>Plast Reconstr Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008.</ArticleTitle>
        <Pagination>
          <StartPage>790</StartPage>
          <EndPage>793</EndPage>
          <MedlinePgn>790-793</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/PRS.0b013e318199edeb</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In the past, concerns about lymphoma among women with breast implants have been raised by anecdotal observations. A recent report of a case-control study from The Netherlands reported an association of breast implants with anaplastic large T-cell lymphoma, but limitations inherent in the study design and the restriction of the association to saline implants preclude any causal evaluation.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">To determine whether lymphoma risk is in fact elevated in women with breast implants, the authors have reviewed the evidence from five long-term follow-up studies comprising over 43,000 women with cosmetic breast implants followed for up to 37 years, which reported results specifically regarding the incidence of non-Hodgkin's lymphoma, among other cancers.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, there were 48 observed incident cases of non-Hodgkin's lymphoma compared with 53.9 cases expected, yielding a summary standardized incidence ratio of 0.89 (95 percent confidence interval, 0.67 to 1.18). None of the epidemiologic cohort studies reported a primary lymphoma originating in the breast.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To date, there is no credible evidence of an increase of non-Hodgkin's lymphoma regardless of site or specifically originating in the breast among women with cosmetic breast implants.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lipworth</LastName>
            <ForeName>Loren</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Rockville, Md.; and Nashville, Tenn. From the International Epidemiology Institute, Vanderbilt University Medical Center, and Vanderbilt-Ingram Cancer Center.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tarone</LastName>
            <ForeName>Robert E</ForeName>
            <Initials>RE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>McLaughlin</LastName>
            <ForeName>Joseph K</ForeName>
            <Initials>JK</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Plast Reconstr Surg</MedlineTA>
        <NlmUniqueID>1306050</NlmUniqueID>
        <ISSNLinking>0032-1052</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D018427" MajorTopicYN="N">Breast Implants</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008228" MajorTopicYN="N">Lymphoma, Non-Hodgkin</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>12</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2009</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2009</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2009</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">19319041</ArticleId>
        <ArticleId IdType="doi">10.1097/PRS.0b013e318199edeb</ArticleId>
        <ArticleId IdType="pii">00006534-200903000-00003</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Newman MK, Zemmel MJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: A case report and review of the literature. J Plast Reconstr Aesthet Surg. 2006;61:822–824.</Citation>
        </Reference>
        <Reference>
          <Citation>Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. Breast lymphoma associated with breast implants: Two case reports and a review of the literature. Leuk Lymphoma 2002;43:115–119.</Citation>
        </Reference>
        <Reference>
          <Citation>Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: A case report and review of the literature. Arch Pathol Lab Med. 2003;127:e115–e118.</Citation>
        </Reference>
        <Reference>
          <Citation>Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100:554–555.</Citation>
        </Reference>
        <Reference>
          <Citation>Duvic M, Moore D, Menter A, Vonderheid EC. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol. 1995;32:939–942.</Citation>
        </Reference>
        <Reference>
          <Citation>Brinton LA. The relationship of silicone breast implants and cancer at other sites. Plast Reconstr Surg. 2007;120(Suppl 1):94S–102S.</Citation>
        </Reference>
        <Reference>
          <Citation>De Jong D, Vasmel WLE, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008;300:2030–2035.</Citation>
        </Reference>
        <Reference>
          <Citation>Lipworth L, Tarone RE, Friis S, et al. Cancer among Scandinavian women with cosmetic breast implants: A pooled long-term follow-up study. Int J Cancer 2008;124:490–493.</Citation>
        </Reference>
        <Reference>
          <Citation>Deapen DM, Hirsch EM, Brody GS. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg. 2007;119:1987–1992.</Citation>
        </Reference>
        <Reference>
          <Citation>Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 2006;118:2854–2862.</Citation>
        </Reference>
        <Reference>
          <Citation>Pukkala E, Boice JD Jr, Hovi SL, et al. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants 2002;12:271–279.</Citation>
        </Reference>
        <Reference>
          <Citation>Brinton LA, Lubin JH, Burich MC, et al. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol. 2001;11:248–256.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
